Verapamil metabolites: potential P-glycoprotein-mediated multidrug resistance reversal agents

By Woodland Cindy   Koren Gideon   Wainer Irving W   Batist Gerry   Ito Shinya  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 8, 2003-08 ,pp. : 800-805

NRC Research Press

Access to resources Recommend Favorite

The p38 MAPK Inhibitor SB203580 Blocks Adenosine A₁ Receptor-Induced Attenuation of In Vivo Myocardial Stunning

By Yoshimura Yukihiro   Kristo Gentian   Keith Byron   Jahania Salik   Mentzer Robert   Lasley Robert  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 6, 2004-11 ,pp. : 433-440

Springer Publishing Company

Access to resources Recommend Favorite

Combating P-glycoprotein-Mediated Multidrug Resistance Using Therapeutic Nanoparticles

By  

Current Pharmaceutical Design, Vol. 19, Iss. 37, 2013-11 ,pp. : 6655-6666

Bentham Science Publishers

Access to resources Recommend Favorite

Reversal of P-glycoprotein associated multidrug resistance by new isoprenoid derivatives

By Hayashi1 M.   Koike2 K.   Rho14 M-C.   Kuwano3 M.   Kishiye2 T.   Komiyama1 K.  

Anti-Cancer Drug Design, Vol. 16, Iss. 4, 2001-08 ,pp. : 255-260

Cognizant Communication Corporation

Access to resources Recommend Favorite

Dihidro-&bgr;-Agarofuran Sesquiterpenes: A New Class of Reversal Agents of the Multidrug Resistance Phenotype Mediated by P-Glycoprotein in the Protozoan Parasite Leishmania

By  

Current Pharmaceutical Design, Vol. 11, Iss. 24, 2005-09 ,pp. : 3125-3139

Bentham Science Publishers

Access to resources Recommend Favorite